Patent · US Active

FSTL-1 as a biomaker of inflammation

US8211652B2 · kind B2 · utility

2Cited by

14References

4Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventor

Raphael Hirsch · Pittsburgh, US

Key dates

Filing date	Jan 29, 2009
Grant date	Jul 3, 2012
Priority date	—
Expiry date	Jan 29, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/26
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides methods and kits for diagnosing severity of particular types of inflammatory diseases, such as rheumatic diseases, by assessing protein levels of follistatin-like protein 1 (FSTL-1). The level of FSTL-1 protein present in the serum or synovial fluid of individuals suspected of having certain inflammatory disease (e.g, rheumatoid arthritis) is positively correlated with the severity of the disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.